COVID-19 long haulers – “With the risks of drug development prohibitive, repurposed or repositioned medicines appear the best hope against long-COVID, a condition that still raises many unanswered questions”.
17 Aug, 2021 | 08:57h | UTCCOVID-19 long haulers – Nature Biotechnology
Related: M-A: More than 50 long-term effects of COVID-19. (several articles on the subject)
Commentary on Twitter
A News Feature published in @NatureBiotech reports on how repurposed or repositioned medicines appear to be the best hope against long-COVID. https://t.co/Hc9s2tr8N8 pic.twitter.com/ue2sH4gWzT
— Nature Portfolio (@NaturePortfolio) August 16, 2021